Scientists hunt for early warning sign of dangerous infections in cancer patients
NCT ID NCT05844033
Summary
This study aims to find a more precise blood test to predict which patients with chronic lymphocytic leukemia or multiple myeloma are at highest risk for getting infections. Researchers will analyze blood samples from about 150 adults with these cancers over two years, looking for specific antibody patterns. The goal is to identify a biomarker that could help doctors monitor and protect vulnerable patients before serious infections occur.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Massachusetts General Hospital Cancer Center
Boston, Massachusetts, 02215, United States
Conditions
Explore the condition pages connected to this study.